Lineagen Patents

Patent portfolio assigned to Lineagen (verified via public assignee records). Salt Lake City personal-genomics company (FirstStepDx PLUS chromosomal microarray for autism/developmental delay); acquired by Bionano Genomics in 2020. Patents confirmed via Justia/Google Patents assignee 'Lineagen, Inc.' (genetic-marker patents for ASD); exact count not displayed.